Blend Labs Inc has a consensus price target of $8.13 based on the ratings of 13 analysts. The high is $24 issued by Truist Securities on August 10, 2021. The low is $1 issued by Piper Sandler on May 10, 2023. The 3 most-recent analyst ratings were released by Keefe, Bruyette & Woods, Canaccord Genuity, and Canaccord Genuity on May 10, 2024, May 8, 2024, and March 19, 2024, respectively. With an average price target of $3 between Keefe, Bruyette & Woods, Canaccord Genuity, and Canaccord Genuity, there's an implied -10.98% downside for Blend Labs Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/10/2024 | Buy Now | -10.98% | Keefe, Bruyette & Woods | Jones William | $2.65 → $3 | Maintains | Market Perform | Get Alert |
05/08/2024 | Buy Now | -10.98% | Canaccord Genuity | Joseph Vafi | $3 → $3 | Maintains | Hold | Get Alert |
03/19/2024 | Buy Now | -10.98% | Canaccord Genuity | Joseph Vafi | $2 → $3 | Maintains | Hold | Get Alert |
03/18/2024 | Buy Now | -10.98% | Canaccord Genuity | Joseph Vafi | $2 → $3 | Maintains | Hold | Get Alert |
03/18/2024 | Buy Now | -21.36% | Keefe, Bruyette & Woods | Jones William | $1.85 → $2.65 | Maintains | Market Perform | Get Alert |
03/15/2024 | Buy Now | -8.01% | Goldman Sachs | Michael Ng | $1.6 → $3.1 | Maintains | Buy | Get Alert |
12/20/2023 | Buy Now | 3.86% | Wells Fargo | Michael Turrin | $1.5 → $3.5 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/08/2023 | Buy Now | -52.52% | Goldman Sachs | Michael Ng | $1.4 → $1.6 | Maintains | Buy | Get Alert |
09/27/2023 | Buy Now | -40.65% | Canaccord Genuity | Joseph Vafi | → $2 | Reiterates | Hold → Hold | Get Alert |
08/15/2023 | Buy Now | -40.65% | Canaccord Genuity | Joseph Vafi | → $2 | Reiterates | Hold → Hold | Get Alert |
08/10/2023 | Buy Now | -55.49% | Wells Fargo | Michael Turrin | $1 → $1.5 | Maintains | Equal-Weight | Get Alert |
05/15/2023 | Buy Now | -61.42% | Keefe, Bruyette & Woods | Ryan Tomasello | $1.4 → $1.3 | Maintains | Market Perform | Get Alert |
05/15/2023 | Buy Now | -40.65% | Canaccord Genuity | Joseph Vafi | → $2 | Reiterates | Hold → Hold | Get Alert |
05/11/2023 | Buy Now | -61.42% | Goldman Sachs | Michael Ng | $1.5 → $1.3 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | -70.33% | Piper Sandler | Arvind Ramnani | $1.3 → $1 | Maintains | Neutral | Get Alert |
05/10/2023 | Buy Now | -70.33% | Wells Fargo | Michael Turrin | $1.5 → $1 | Maintains | Equal-Weight | Get Alert |
05/10/2023 | Buy Now | -61.42% | Goldman Sachs | Michael Ng | $1.5 → $1.3 | Maintains | Buy | Get Alert |
04/28/2023 | Buy Now | -55.49% | Goldman Sachs | Michael Ng | $2.5 → $1.5 | Maintains | Buy | Get Alert |
03/20/2023 | Buy Now | -61.42% | Piper Sandler | Arvind Ramnani | $2.4 → $1.3 | Maintains | Neutral | Get Alert |
03/17/2023 | Buy Now | -55.49% | Wells Fargo | Michael Turrin | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
03/17/2023 | Buy Now | -40.65% | Canaccord Genuity | Joseph Vafi | $3 → $2 | Maintains | Hold | Get Alert |
03/09/2023 | Buy Now | -58.46% | Keefe, Bruyette & Woods | Ryan Tomasello | $1.3 → $1.4 | Maintains | Market Perform | Get Alert |
01/11/2023 | Buy Now | -40.65% | Wells Fargo | Michael Turrin | $2.5 → $2 | Maintains | Equal-Weight | Get Alert |
11/14/2022 | Buy Now | -10.98% | Canaccord Genuity | Joseph Vafi | $4 → $3 | Maintains | Hold | Get Alert |
11/14/2022 | Buy Now | -33.23% | Keefe, Bruyette & Woods | Ryan Tomasello | → $2.25 | Upgrade | Underperform → Market Perform | Get Alert |
11/11/2022 | Buy Now | -25.82% | Wells Fargo | Michael Turrin | $3 → $2.5 | Maintains | Equal-Weight | Get Alert |
11/11/2022 | Buy Now | -28.78% | Piper Sandler | Arvind Ramnani | $3.2 → $2.4 | Maintains | Neutral | Get Alert |
10/18/2022 | Buy Now | -3.56% | Goldman Sachs | Michael Ng | $5.25 → $3.25 | Maintains | Buy | Get Alert |
08/19/2022 | Buy Now | 18.69% | Canaccord Genuity | Joseph Vafi | $5 → $4 | Maintains | Hold | Get Alert |
08/16/2022 | Buy Now | -5.04% | Piper Sandler | Arvind Ramnani | $2.5 → $3.2 | Maintains | Neutral | Get Alert |
07/25/2022 | Buy Now | -18.4% | Keefe, Bruyette & Woods | Ryan Tomasello | $4 → $2.75 | Downgrade | Market Perform → Underperform | Get Alert |
07/18/2022 | Buy Now | -25.82% | Piper Sandler | Arvind Ramnani | $3.5 → $2.5 | Maintains | Neutral | Get Alert |
07/07/2022 | Buy Now | 48.37% | Keybanc | Josh Beck | → $5 | Downgrade | Overweight → Sector Weight | Get Alert |
05/25/2022 | Buy Now | 24.63% | Compass Point | Jason Weaver | → $4.2 | Initiates | → Neutral | Get Alert |
05/13/2022 | Buy Now | 3.86% | Piper Sandler | Arvind Ramnani | $5.5 → $3.5 | Maintains | Neutral | Get Alert |
05/13/2022 | Buy Now | -10.98% | Wells Fargo | Michael Turrin | $5 → $3 | Maintains | Equal-Weight | Get Alert |
04/19/2022 | Buy Now | 107.72% | Goldman Sachs | Michael Ng | $8 → $7 | Maintains | Buy | Get Alert |
04/04/2022 | Buy Now | 137.39% | Goldman Sachs | Michael Ng | $9 → $8 | Maintains | Buy | Get Alert |
04/04/2022 | Buy Now | — | William Blair | Bhavan Suri | — | Downgrade | Outperform → Market Perform | Get Alert |
04/01/2022 | Buy Now | 63.2% | Truist Securities | Terry Tillman | $7.5 → $5.5 | Maintains | Hold | Get Alert |
04/01/2022 | Buy Now | 48.37% | Canaccord Genuity | Joseph Vafi | $28 → $5 | Downgrade | Buy → Hold | Get Alert |
04/01/2022 | Buy Now | 48.37% | Wells Fargo | Michael Turrin | → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/01/2022 | Buy Now | 63.2% | Piper Sandler | Arvind Ramnani | $10 → $5.5 | Downgrade | Overweight → Neutral | Get Alert |
04/01/2022 | Buy Now | 78.04% | Keybanc | Josh Beck | $10 → $6 | Maintains | Overweight | Get Alert |
03/31/2022 | Buy Now | 167.06% | Goldman Sachs | Michael Ng | $23 → $9 | Maintains | Buy | Get Alert |
03/21/2022 | Buy Now | 122.55% | Truist Securities | Terry Tillman | → $7.5 | Downgrade | Buy → Hold | Get Alert |
03/15/2022 | Buy Now | 226.41% | Wells Fargo | Michael Turrin | $15 → $11 | Maintains | Overweight | Get Alert |
02/14/2022 | Buy Now | 248.66% | Keefe, Bruyette & Woods | Ryan Tomasello | → $11.75 | Initiates | → Market Perform | Get Alert |
01/25/2022 | Buy Now | 196.74% | Keybanc | Josh Beck | $16 → $10 | Maintains | Overweight | Get Alert |
01/13/2022 | Buy Now | 196.74% | Piper Sandler | Arvind Ramnani | $13 → $10 | Maintains | Overweight | Get Alert |
12/13/2021 | Buy Now | 345.1% | Wells Fargo | Michael Turrin | — | Maintains | Overweight | Get Alert |
12/10/2021 | Buy Now | 285.76% | Piper Sandler | Arvind Ramnani | — | Maintains | Overweight | Get Alert |
11/12/2021 | Buy Now | 374.78% | Keybanc | Josh Beck | — | Maintains | Overweight | Get Alert |
11/11/2021 | Buy Now | 463.8% | Piper Sandler | Arvind Ramnani | — | Maintains | Overweight | Get Alert |
08/20/2021 | Buy Now | 552.82% | Keybanc | Josh Beck | — | Maintains | Overweight | Get Alert |
08/10/2021 | Buy Now | 493.47% | UBS | Karl Keirstead | — | Initiates | → Neutral | Get Alert |
08/10/2021 | Buy Now | 612.17% | Wells Fargo | Michael Turrin | — | Initiates | → Overweight | Get Alert |
08/10/2021 | Buy Now | — | William Blair | Bhavan Suri | — | Initiates | → Outperform | Get Alert |
08/10/2021 | Buy Now | 730.86% | Canaccord Genuity | Joseph Vafi | — | Initiates | → Buy | Get Alert |
08/10/2021 | Buy Now | 612.17% | Truist Securities | — | — | Initiates | → Buy | Get Alert |
08/10/2021 | Buy Now | 790.21% | Goldman Sachs | Michael Ng | — | Initiates | → Buy | Get Alert |
08/10/2021 | Buy Now | 641.84% | Keybanc | Josh Beck | — | Initiates | → Overweight | Get Alert |
08/10/2021 | Buy Now | 612.17% | Piper Sandler | Justin Patterson | — | Initiates | → Overweight | Get Alert |
The latest price target for Blend Labs (NYSE:BLND) was reported by Keefe, Bruyette & Woods on May 10, 2024. The analyst firm set a price target for $3.00 expecting BLND to fall to within 12 months (a possible -10.98% downside). 11 analyst firms have reported ratings in the last year.
The latest analyst rating for Blend Labs (NYSE:BLND) was provided by Keefe, Bruyette & Woods, and Blend Labs maintained their market perform rating.
The last upgrade for Blend Labs Inc happened on December 20, 2023 when Wells Fargo raised their price target to $3.5. Wells Fargo previously had an equal-weight for Blend Labs Inc.
The last downgrade for Blend Labs Inc happened on July 25, 2022 when Keefe, Bruyette & Woods changed their price target from $4 to $2.75 for Blend Labs Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Blend Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Blend Labs was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
While ratings are subjective and will change, the latest Blend Labs (BLND) rating was a maintained with a price target of $2.65 to $3.00. The current price Blend Labs (BLND) is trading at is $3.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.